Skillman, NJ, United States of America

Lorena Telofski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Johnson & Johnson Consumer Inc.. Active years: 2023.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorena Telofski: Innovator in Skin Treatment Technologies

Introduction

Lorena Telofski is a notable inventor based in Skillman, NJ (US). She has made significant contributions to the field of skin treatment through her innovative methods and research. Her work focuses on enhancing the effectiveness of skin care products by utilizing scientific approaches to treatment regimens.

Latest Patents

Lorena holds a patent for a "Method of selecting skin treatment regimens, ingredients and compositions." This patent describes a method that includes measuring the levels of particular small molecule metabolites on the skin both before and after product application. The method tests for changes in small molecule metabolite levels, providing a scientific basis for selecting effective skin treatments.

Career Highlights

Lorena Telofski is associated with Johnson & Johnson Consumer Inc., where she applies her expertise in skin treatment technologies. Her work at this prominent company allows her to contribute to the development of innovative skin care solutions that benefit consumers.

Collaborations

Throughout her career, Lorena has collaborated with esteemed colleagues, including Kimberly A Capone and Georgios N Stamatas. These collaborations have further enriched her research and development efforts in the field of skin treatment.

Conclusion

Lorena Telofski's innovative approach to skin treatment regimens exemplifies the intersection of science and consumer health. Her contributions continue to influence the industry and improve the effectiveness of skin care products.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…